Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tommysdad who wrote (2672)	11/6/1997 10:58:00 PM
From: JOHN W.	Read Replies (1) of 6136

Montgomery's analyst that went to a "hold" after ICAAC based as on similiar reason of lifespan of the drug. Obviously there are many including myself that disagree. I am fairly certain it is "Crossen", not "Crosson". P.S. I do not think there was any big news from the shareholders mtg,. The people that we often talk to, (Machelle, Sherry, Donna) all seemed very nice. It was a pleasure to meet them. I even met Patricia M. Cloherty who also was great.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next